---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-017381"
form_type: "8-K"
ticker: null
cik: "0001850051"
company_name: "Intelligent Medicine Acquisition Corp."
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T20:57:02.794571+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# IQMD shareholders approve extension to Sep 9, 2023; 20M shares redeemed for ~$207M

## Summary
- Extension approved: deadline to close business combination moved from Feb 9 to Sep 9, 2023.
- Holders of 20,009,861 public shares exercised redemption rights at ~$10.34/share, totaling ~$206.9M.
- Sponsor contributed 200,000 Class B shares to trust; will own 80.1% of outstanding Class A (if converted).
- Proposals 1 & 2 passed with ~78.7% of votes cast in favor; Adjournment Proposal not voted.
- Sponsor also holds private warrants for 9,245,000 Class A shares, currently not exercisable.

## SEC filing metadata
- accession: 0001104659-23-017381
- form_type: 8-K
- cik: 0001850051
- company_name: Intelligent Medicine Acquisition Corp.
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/0001104659-23-017381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/tm236108d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-017381
- JSON: https://secwatch.observer/filing/0001104659-23-017381.json
- Plain text: https://secwatch.observer/filing/0001104659-23-017381.txt

## Key facts
- Governance Changes
  Intelligent Medicine Acquisition Corp.: The Company filed an amendment to its Amended and Restated Certificate of Incorporation to extend the deadline to consummate a business combination from February 9, 2023 to September 9, 2023 (effective 2023-02-08).
  - Change: charter amendment
  - Effective: 2023-02-08
  source text: On February 8, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) filed an amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the State of Delaware., The Amendment is attached as Exhibit 3.1 hereto and the full text of such exhibit is incorporated by reference herein.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/0001104659-23-017381-index.htm
- Shareholder Votes
  Intelligent Medicine Acquisition Corp. shareholders approved Extension Amendment Proposal: to amend the certificate of incorporation to extend the business combination deadline at the 2023-02-08 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-02-08
  source text: Proposal No. 1: The Extension Amendment Proposal: T o amend the Company’s amended and restated certificate of incorporation by allowing the Company to extend the date by which it has to consummate a business combination for an additional seven (7) months, from February 9, 2023 to September 9, 2023, or such earlier date as determined by the Company’s board of directors, conditioned on the deposit of 200,000 shares of Class B common stock into the Company’s IPO Trust Account. FOR AGAINST ABSTAIN 17,071,690 4,600,300 3,936
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/0001104659-23-017381-index.htm
- Shareholder Votes
  Intelligent Medicine Acquisition Corp. shareholders approved Trust Amendment Proposal: to amend the Investment Management Trust Agreement at the 2023-02-08 meeting.
  - Outcome: passed
  - Meeting: 2023-02-08
  source text: Proposal No. 2 The Trust Amendment Proposal: To amend the Investment Management Trust Agreement, dated November 4, 2021, by and between the Company and Continental Stock Transfer & Company to authorize the Extension and its implementation by the Company. FOR AGAINST ABSTAIN 17,071,841 4,600,149 3,936
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850051/000110465923017381/0001104659-23-017381-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.